CoreMap, Inc.
Biotechnology company · Burlington, Massachusetts, United States
CoreMap, Inc. is a biotechnology company headquartered in Burlington, Massachusetts, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $6.8 million sold in a notice filed in 2025.
CoreMap at a glance
What does CoreMap do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $6.8 million sold (2025).
Frequently asked questions about CoreMap
Where is CoreMap headquartered?
CoreMap, Inc. is headquartered in Burlington, Massachusetts, United States.
What does CoreMap do?
CoreMap, Inc. is a biotechnology company.
When was CoreMap founded?
The earliest incorporation on record for CoreMap, Inc. is in 2016, according to public company registers.
Similar companies
- Vericel CorpBurlington, Massachusetts, United States
- Cardurion Pharmaceuticals, Inc.Burlington, Massachusetts, United States
- Consano Bio, Inc.Burlington, Massachusetts, United States
- MakscientificBurlington, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences